Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Susan A M Mulders"'
Autor:
Anchel González-Barriga, Julia Kranzen, Huib J E Croes, Suzanne Bijl, Walther J A A van den Broek, Ingeborg D G van Kessel, Baziel G M van Engelen, Judith C T van Deutekom, Bé Wieringa, Susan A M Mulders, Derick G Wansink
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121556 (2015)
Myotonic Dystrophy type 1 (DM1) is a multisystemic disease caused by toxic RNA from a DMPK gene carrying an expanded (CTG•CAG)n repeat. Promising strategies for treatment of DM1 patients are currently being tested. These include antisense oligonucl
Externí odkaz:
https://doaj.org/article/e315422256e242feba27e3e2c97a4a55
Autor:
Melvin M Evers, Barry A Pepers, Judith C T van Deutekom, Susan A M Mulders, Johan T den Dunnen, Annemieke Aartsma-Rus, Gert-Jan B van Ommen, Willeke M C van Roon-Mom
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24308 (2011)
To date there are 9 known diseases caused by an expanded polyglutamine repeat, with the most prevalent being Huntington's disease. Huntington's disease is a progressive autosomal dominant neurodegenerative disorder for which currently no therapy is a
Externí odkaz:
https://doaj.org/article/8fcae1147e504440b8318728c2011151
Autor:
Bram Nillessen, H.J.E. Croes, Begoña Aguilera, Peter C de Visser, Derick G. Wansink, Susan A. M. Mulders, Bé Wieringa, Julia Kranzen, Ingeborg D.G. van Kessel, Nicole A. Datson, Judith C.T. van Deutekom, Anchel González-Barriga
Publikováno v:
Nucleic Acid Therapeutics, 27, 144-158
Nucleic Acid Therapeutics
Nucleic Acid Therapeutics, 27, 3, pp. 144-158
Nucleic Acid Therapeutics
Nucleic Acid Therapeutics, 27, 3, pp. 144-158
Contains fulltext : 174425.pdf (Publisher’s version ) (Closed access) Clinical efficacy of antisense oligonucleotides (AONs) for the treatment of neuromuscular disorders depends on efficient cellular uptake and proper intracellular routing to the t
Autor:
Nicole A. Datson, Taneli Heikkinen, Eleni Kourkouta, Outi Kontkanen, Rudie Weij, Anchel González-Barriga, Jeroen van de Giessen, Susan A. M. Mulders, Judith C.T. van Deutekom, Kimmo Lehtimäki
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171127 (2017)
PLoS ONE
PLoS ONE
The aim of these studies was to demonstrate the therapeutic capacity of an antisense oligonucleotide with the sequence (CUG)7 targeting the expanded CAG repeat in huntingtin (HTT) mRNA in vivo in the R6/2 N-terminal fragment and Q175 knock-in Hunting
Autor:
Miranda B. Bennink, Susan A. M. Mulders, Mietske Wijers, Jack A.M. Fransen, Remco van Horssen, Fons A. J. van de Loo, Bé Wieringa, Roelie T. de Boer-van Huizen, Lieke Gerrits, H.J.E. Croes, Helma Pluk, Derick G. Wansink
Publikováno v:
Biochimica et Biophysica Acta. Molecular Cell Research, 1813, 5, pp. 867-77
Biochimica et Biophysica Acta. Molecular Cell Research, 1813, 867-77
ResearcherID
Biochimica et Biophysica Acta. Molecular Cell Research, 1813, 867-77
ResearcherID
Contains fulltext : 97603.pdf (Publisher’s version ) (Closed access) DMPK, the product of the mutated gene in myotonic dystrophy type 1, belongs to the subfamily of Rho-associated serine-threonine protein kinases, whose members play a role in actin
Publikováno v:
Human Molecular Genetics, 19, R90-7
Human Molecular Genetics, 19, R1, pp. R90-7
Human Molecular Genetics, 19, R1, pp. R90-7
Contains fulltext : 89133.pdf (Publisher’s version ) (Closed access) Myotonic dystrophy (DM) is a complex, dominantly inherited, multisystem disorder and the archetypal example of an RNA gain-of-function disease. Unstable expansions of (CTG*CAG)n o
Autor:
Geneviève Gourdon, Sjef J. de Kimpe, Gerard Johannes Platenburg, Derick G. Wansink, Charles A. Thornton, Bé Wieringa, Walther J. A. A. van den Broek, Susan A. M. Mulders, Thurman M. Wheeler, Denis Furling, H.J.E. Croes, Petra Van Kuik-Romeijn
Publikováno v:
Proceedings of the National Academy of Sciences USA, 106, 13915-20
Proceedings of the National Academy of Sciences USA, 106, 33, pp. 13915-20
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2009, 106 (33), pp.13915-13920. ⟨10.1073/pnas.0905780106⟩
Proceedings of the National Academy of Sciences USA, 106, 33, pp. 13915-20
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2009, 106 (33), pp.13915-13920. ⟨10.1073/pnas.0905780106⟩
Contains fulltext : 81075.pdf (Publisher’s version ) (Closed access) Myotonic dystrophy type 1 (DM1) is caused by toxicity of an expanded, noncoding (CUG)n tract in DM protein kinase (DMPK) transcripts. According to current evidence the long (CUG)n
Autor:
Derick G. Wansink, Walther J. A. A. van den Broek, Judith C.T. van Deutekom, Suzanne Bijl, Anchel González-Barriga, Ingeborg D.G. van Kessel, Bé Wieringa, Julia Kranzen, H.J.E. Croes, Baziel G.M. van Engelen, Susan A. M. Mulders
Publikováno v:
PLoS ONE
PLoS One, 10, 3
PLoS ONE, Vol 10, Iss 3, p e0121556 (2015)
PLoS One, 10
PLoS One, 10, 3
PLoS ONE, Vol 10, Iss 3, p e0121556 (2015)
PLoS One, 10
Contains fulltext : 154719.pdf (Publisher’s version ) (Open Access) Myotonic Dystrophy type 1 (DM1) is a multisystemic disease caused by toxic RNA from a DMPK gene carrying an expanded (CTG*CAG)n repeat. Promising strategies for treatment of DM1 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ff32d2a42b406e64a60b483f7f2219
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/154719
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/154719
Autor:
Susan A. M. Mulders, Barry A. Pepers, Gert-Jan B. van Ommen, Annemieke Aartsma-Rus, Willeke M. C. van Roon-Mom, Johan T. den Dunnen, Judith C.T. van Deutekom, Melvin M. Evers
Publikováno v:
PLoS ONE, 6(9)
PLoS ONE
PLoS ONE, Vol 6, Iss 9, p e24308 (2011)
PLoS One, 6
PLoS One, 6, 9
PLoS ONE
PLoS ONE, Vol 6, Iss 9, p e24308 (2011)
PLoS One, 6
PLoS One, 6, 9
Contains fulltext : 98397.pdf (Publisher’s version ) (Open Access) To date there are 9 known diseases caused by an expanded polyglutamine repeat, with the most prevalent being Huntington's disease. Huntington's disease is a progressive autosomal do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7889034952a2cfded08ac3ee5adf5e69
http://hdl.handle.net/1887/118127
http://hdl.handle.net/1887/118127
Autor:
Derick G. Wansink, Ralph J. A. Oude Ophuis, Susan A. M. Mulders, Rinske van de Vorstenbosch, Bé Wieringa, René E. M. A. van Herpen
Publikováno v:
Muscle and Nerve, 40, 4, pp. 545-55
Muscle and Nerve, 40, 545-55
Muscle and Nerve, 40, 545-55
Contains fulltext : 79892.pdf (Publisher’s version ) (Closed access) Myotonic dystrophy type 1 (DM1) is a neuromuscular disorder caused by an unstable (CTG . CAG)n segment in the 3' untranslated region of the myotonic dystrophy protein kinase (DMPK